Nasdaq Arct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bank Julius Baer & Co. Ltd Zurich trimmed its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 18.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,232 shares of the biotechnology company’s stock after selling 11,028 […]

Federated Hermes Inc. trimmed its holdings in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 1.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,711,512 shares of the biotechnology company’s stock after selling 66,988 shares during the quarter. Federated Hermes Inc. […]

Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have been given a consensus rating of “Buy” by the six analysts that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have issued a report on the […]

Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have earned a consensus recommendation of “Buy” from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued a report on […]

Equities research analysts at Canaccord Genuity Group began coverage on shares of Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) in a research report issued on Wednesday, Benzinga reports. The brokerage set a “buy” rating on the biotechnology company’s stock. A number of other equities analysts also recently commented on the company. StockNews.com began coverage on […]